当前位置:首页 - 行情中心 - 莱茵生物(002166) - 财务分析 - 现金流量表

莱茵生物

(002166)

  

流通市值:57.96亿  总市值:58.36亿
流通股本:7.36亿   总股本:7.42亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,056,035,394.49594,106,387.961,888,280,454.121,438,826,870.38
  收到的税费返还20,626,504.666,313,359.9570,908,816.4566,130,272.44
  收到其他与经营活动有关的现金6,048,776.053,670,545.8722,652,31816,738,483.97
  经营活动现金流入小计1,082,710,675.2604,090,293.781,981,841,588.571,521,695,626.79
  购买商品、接受劳务支付的现金603,291,753.05326,250,630.191,415,577,326.371,047,088,689.31
  支付给职工以及为职工支付的现金104,261,122.7657,265,330.15185,707,033.63136,483,035.22
  支付的各项税费34,739,231.0617,422,333.6753,134,538.1836,851,920.47
  支付其他与经营活动有关的现金45,641,368.2620,215,885.78167,709,093.35158,535,527.71
  经营活动现金流出小计787,933,475.13421,154,179.791,822,127,991.531,378,959,172.71
  经营活动产生的现金流量净额294,777,200.07182,936,113.99159,713,597.04142,736,454.08
二、投资活动产生的现金流量:
  收回投资收到的现金380,839.5236,454.084,124,071.862,496,073.11
  取得投资收益收到的现金15,047.83-7,362,916.27,362,916.12
  处置固定资产、无形资产和其他长期资产收回的现金净额104,348103,348109,03059,480
  投资活动现金流入小计500,235.35139,802.0811,596,018.069,918,469.23
  购建固定资产、无形资产和其他长期资产支付的现金85,226,314.7253,324,549.53207,081,135.72157,657,032.66
  投资活动现金流出小计85,226,314.7253,324,549.53207,081,135.72157,657,032.66
  投资活动产生的现金流量净额-84,726,079.37-53,184,747.45-195,485,117.66-147,738,563.43
三、筹资活动产生的现金流量:
  取得借款收到的现金503,848,408.5291,889,156.5942,894,636833,756,045
  收到其他与筹资活动有关的现金-5,099,252319,100,00018,900,000
  筹资活动现金流入小计503,848,408.5296,988,408.51,261,994,636852,656,045
  偿还债务支付的现金500,010,092.5211,020,092.5703,570,255498,584,059
  分配股利、利润或偿付利息支付的现金93,938,443.5811,355,735.38190,320,195.79179,781,071.39
  支付其他与筹资活动有关的现金47,245,130.9246,523,380.21397,863,799.9284,937,059.36
  筹资活动现金流出小计641,193,667268,899,208.091,291,754,250.71763,302,189.75
  筹资活动产生的现金流量净额-137,345,258.528,089,200.41-29,759,614.7189,353,855.25
四、汇率变动对现金及现金等价物的影响1,563,464.92882,805.761,636,118.971,297,474.72
五、现金及现金等价物净增加额74,269,327.12158,723,372.71-63,895,016.3685,649,220.62
  加:期初现金及现金等价物余额49,769,406.3549,769,406.35113,664,422.71113,664,422.71
  期末现金及现金等价物余额124,038,733.47208,492,779.0649,769,406.35199,313,643.33
补充资料:
  净利润43,672,421.11-167,173,992.57-
  资产减值准备422,147.6-21,463,296.06-
  固定资产和投资性房地产折旧60,963,155.65-94,197,003.43-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧60,963,155.65-94,197,003.43-
  无形资产摊销2,514,229.17-4,589,958.37-
  长期待摊费用摊销565,772.46-4,253,880.75-
  处置固定资产、无形资产和其他长期资产的损失109,497.53-523,831.47-
  固定资产报废损失942,659.52-1,116,976.43-
  公允价值变动损失207,129.89--2,025,062.21-
  财务费用19,396,828.1-41,281,141.03-
  投资损失-74,624.01--7,178,829-
  递延所得税2,321,545.33-951,847.94-
  其中:递延所得税资产减少872,809.53--2,820,177.9-
    递延所得税负债增加1,448,735.8-3,772,025.84-
  存货的减少30,610,947.13--237,129,675-
  经营性应收项目的减少172,473,105.21-8,251,296.59-
  经营性应付项目的增加-39,426,464.42-42,370,133.3-
  其他-1,590,905.19-16,076,345.8-
  现金的期末余额124,038,733.47-49,769,406.35-
  减:现金的期初余额49,769,406.35-113,664,422.71-
  现金及现金等价物的净增加额74,269,327.12--63,895,016.36-
公告日期2025-08-292025-04-262025-03-282024-10-31
审计意见(境内)标准无保留意见
TOP↑